MAZE
Maze Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$28.29+0.60%
Price as of Jul 20, 2026
MAZE ownership
Maze Therapeutics, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
21
Net (3m)
-$4.6M
Insider trades by month Buys Sells
Feb
Mar
Apr
May
Jun
Jul
Context3-month price -3.3%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 2, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 30,311 | $29.95 |
| Jul 2, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 2,593 | $29.98 |
| Jul 2, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Option | 14,609 | $10.42 |
| Jul 2, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 1,597 | $30.44 |
| Jul 2, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Sell | 1,200 | $30.34 |
| Jul 2, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Sell | 13,409 | $29.86 |
| Jul 1, 2026 | Dandekar Atulofficer: CSBO | Option | 7,500 | $10.42 |
| Jul 1, 2026 | Dandekar Atulofficer: CSBO | Sell | 7,500 | $28.02 |
| Jun 24, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 2,040 | $26.00 |
| Jun 24, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 1,953 | $26.00 |
| Jun 24, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 23,865 | $26.05 |
| Jun 10, 2026 | Andrews Nancy Cdirector | Grant | 18,000 | $23.58 |
| Jun 10, 2026 | HOMCY CHARLES Jdirector | Grant | 18,000 | $23.58 |
| Jun 10, 2026 | Hoppenot Hervedirector | Grant | 18,000 | $23.58 |
| Jun 10, 2026 | SPIEGELMAN DANIEL Kdirector | Grant | 18,000 | $23.58 |
| Jun 10, 2026 | SCHELLER RICHARD Hdirector | Grant | 18,000 | $23.58 |
| Jun 10, 2026 | Lim Jonathan Edirector | Grant | 18,000 | $23.58 |
| Jun 3, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Sell | 1,600 | $26.36 |
| Jun 3, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 6,090 | $26.20 |
| Jun 3, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 553 | $26.24 |
| Jun 3, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Option | 14,853 | $10.42 |
| Jun 3, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Sell | 13,253 | $25.57 |
| Jun 2, 2026 | Dandekar Atulofficer: CSBO | Option | 7,500 | $10.42 |
| Jun 2, 2026 | Dandekar Atulofficer: CSBO | Sell | 7,500 | $26.34 |
| May 27, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 2,478 | $26.00 |
| May 27, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 4,504 | $26.00 |
| May 27, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 25,582 | $26.02 |
| May 18, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Option | 15,000 | $10.42 |
| May 18, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 116 | $26.00 |
| May 18, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 1,822 | $26.00 |
Source: MAZE SEC Form 4 filings, latest Jul 2, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their MAZE positions over the last 6 months (SEC Form 13F).
Increased
103
New positions
109
Reduced
57
Sold out
42
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Unchanged | 4.6M | May 15, 2026 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Unchanged | 4.6M | Feb 13, 2026 |
| TRV GP IV, LLC | Unchanged | 4.5M | May 7, 2026 |
| TRV GP IV, LLC | Reduced | 4.5M | Feb 13, 2026 |
| DEEP TRACK CAPITAL, LP | Increased | 4.2M | Feb 13, 2026 |
| ARCH VENTURE MANAGEMENT, LLC | Unchanged | 4.1M | Feb 17, 2026 |
| ARCH VENTURE MANAGEMENT, LLC | Unchanged | 4.1M | May 15, 2026 |
| DEEP TRACK CAPITAL, LP | Reduced | 3.5M | May 15, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 3.1M | Feb 17, 2026 |
| JANUS HENDERSON GROUP PLC | Reduced | 2.9M | May 18, 2026 |
| PARADIGM BIOCAPITAL ADVISORS LP | New Position | 2.7M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 2.6M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 2.3M | Feb 12, 2026 |
| AH CAPITAL MANAGEMENT, L.L.C. | Unchanged | 1.7M | May 15, 2026 |
| AH CAPITAL MANAGEMENT, L.L.C. | Unchanged | 1.7M | Feb 17, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.